• (-)-Arctigenin: Mechanistic Rationale for Targeting NF-κB/ME

  2026-07-21

  Explore how (-)-Arctigenin, a potent MEK1 inhibitor, uniquely modulates NF-κB signaling in tumor-associated macrophages. This article offers a mechanistic framework for high-impact research on metastasis and microenvironment regulation.

• Methylprednisolone: Advanced Insights for Preclinical Bone R

  2026-07-21

  Explore how methylprednisolone, a synthetic glucocorticoid receptor agonist, shapes translational bone research. This article delivers in-depth scientific analysis, unique protocol guidance, and advanced insights for modeling inflammation-driven bone loss.

• HyperFluor 488 Goat Anti-Mouse IgG: Elevating Immunofluoresc

  2026-07-20

  The HyperFluor 488 Goat Anti-Mouse IgG (H+L) Antibody enables precise, high-sensitivity detection of mouse immunoglobulins across immunofluorescence, flow cytometry, and western blotting. Its robust signal amplification and low background performance streamline advanced translational workflows, making it indispensable for studies on cellular injury and protein localization.

• Pam3CSK4 as a TLR1/2 Agonist: Advanced Workflows & Solutions

  2026-07-20

  Pam3CSK4 unlocks precise control of TLR1/2-mediated immune activation, making it indispensable for inflammatory and neuro-immune research. This guide details cutting-edge applied use-cases, optimized protocols, and troubleshooting strategies to ensure robust results in both cellular and in vivo inflammation models.

• Biotin-tyramide: Amplifying Sensitivity in IHC and ISH Assay

  2026-07-19

  Biotin-tyramide, a leading biotin phenol-based reagent from APExBIO, unlocks ultra-sensitive detection for immunohistochemistry and in situ hybridization workflows. Its enzyme-mediated signal amplification and robust HRP-catalyzed deposition enable precise spatial mapping and empower advanced molecular discovery, especially in proximity labeling and cancer research.

• Filipin III: Transforming Cholesterol Mapping for Immunometa

  2026-07-18

  Filipin III, a polyene macrolide antibiotic, is revolutionizing the study of cholesterol dynamics in translational immunometabolism. This article explores mechanistic insights, practical protocols, and strategic guidance for translational researchers using Filipin III to illuminate cholesterol’s role in tumor immunity, with evidence from recent studies and advanced imaging workflows. It bridges the gap between fundamental membrane biochemistry and clinical innovation, positioning APExBIO’s Filipin III as an indispensable tool for next-generation immunometabolic research.

• SB 202190: p38 MAP Kinase Inhibitor for Advanced Cancer Mode

  2026-07-17

  SB202190 (FHPI) empowers researchers to dissect p38 MAPK-driven pathways in cancer, inflammation, and neurodegeneration with precision. This guide translates the latest high-content screening innovations and troubleshooting insights into actionable workflows, maximizing the compound’s impact on migration, apoptosis, and disease modeling.

• Berberrubine Chloride: Selective IMPDH2 Inhibition in Colore

  2026-07-17

  Explore how Berberrubine chloride, a potent isoquinoline alkaloid, uniquely targets IMPDH2 to suppress colorectal cancer cell growth. This in-depth review reveals mechanistic insights, translational impact, and optimized protocols for advanced oncology research.

• IGF2BP1-m6A-THBS1 Axis Drives Macrophage-Mediated Pulmonary

  2026-07-16

  This study elucidates how the m6A reader IGF2BP1 promotes pulmonary fibrosis by stabilizing THBS1 mRNA, leading to enhanced macrophage glycolysis and fibrotic polarization. The findings highlight a novel IGF2BP1/THBS1/TLR4 regulatory axis, offering mechanistic insights and potential therapeutic targets in fibrotic lung disease.

• c-Myc tag Peptide: Optimizing Immunoassay Precision & Contro

  2026-07-16

  The c-Myc tag Peptide empowers high-specificity immunoassays by enabling robust displacement of c-Myc-tagged fusion proteins and fine-tuned inhibition of anti-c-Myc antibody binding. This article delivers actionable workflows, troubleshooting strategies, and contextualizes the peptide’s value for transcription factor research and cell signaling studies.

• DOT1L Inhibition Enhances Lenalidomide Response in Myeloma v

  2026-07-15

  This study demonstrates that inhibiting DOT1L, a histone methyltransferase, reprograms innate immune signaling and significantly potentiates the anti-myeloma efficacy of immunomodulatory agents like lenalidomide. The findings reveal key epigenetic–immune interactions and support novel therapeutic strategies for overcoming resistance in multiple myeloma.

• Macrophage EV miR-660 Drives Breast Cancer via KLHL21–NF-κB

  2026-07-15

  This study reveals how macrophage-derived extracellular vesicles (EVs) carrying microRNA-660 (miR-660) promote breast cancer progression by downregulating KLHL21 and activating the IKKβ/NF-κB p65 pathway. These findings highlight a novel tumor-promoting mechanism within the tumor microenvironment and suggest new molecular targets for translational cancer research.

• Bifendate (DDB): Optimizing Hepatoprotection & Lipid Studies

  2026-07-14

  Bifendate (DDB) delivers robust, multi-mechanistic hepatoprotection and lipid regulation for both in vitro and in vivo research. This guide details applied protocols, troubleshooting, and workflow enhancements to maximize reproducibility and translational value using APExBIO's validated formulation.

• Digestion and Metabolic Impact of Triacetin: New Insights fr

  2026-07-14

  This study clarifies the digestive fate and metabolic effects of triacetin, a short-chain triacylglycerol, in rats. By tracking its breakdown and absorption, the paper demonstrates that triacetin is fully degraded in the upper gut and modulates hepatic metabolism, highlighting its dual role as an energy substrate and signaling molecule.

• Cyclophosphamide (SKU A2343): Best Practices for Reliable Ca

  2026-07-13

  This article addresses reproducibility and workflow optimization for apoptosis and immune modulation assays using Cyclophosphamide (SKU A2343). Drawing on scenario-driven lab challenges, it demonstrates why researchers rely on this alkylating chemotherapeutic agent for sensitive, validated protocols in cancer and immunology research.

8306 records 5/554 page Previous Next 12345 下5页 Last page